These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 28116188)
1. Fast-Growing Meningioma in a Woman Undergoing Fertility Treatments. Patterson A; Elashaal A Case Rep Neurol Med; 2016; 2016():3287381. PubMed ID: 28116188 [TBL] [Abstract][Full Text] [Related]
2. Hormonal therapy for fertility and huge meningioma: a purely random association? Frassanito P; De Bonis P; Mattogno PP; Novello M; Anile C Acta Neurol Belg; 2012 Sep; 112(3):299-301. PubMed ID: 22426675 [TBL] [Abstract][Full Text] [Related]
3. Fertility treatment is associated with multiple meningiomas and younger age at diagnosis. Shahin MN; Magill ST; Dalle Ore CL; Viner JA; Peters PN; Solomon DA; McDermott MW J Neurooncol; 2019 May; 143(1):137-144. PubMed ID: 30868355 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery. Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463 [TBL] [Abstract][Full Text] [Related]
5. [A case of rapidly growing dumbbell-shaped convexity meningioma]. Kawahara I; Nakamoto M; Matsuo Y; Tokunaga YI; Abe K No Shinkei Geka; 2009 Jun; 37(6):579-85. PubMed ID: 19522286 [TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900 [TBL] [Abstract][Full Text] [Related]
7. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas. Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539 [TBL] [Abstract][Full Text] [Related]
8. Correlation of volumetric growth and histological grade in 50 meningiomas. Soon WC; Fountain DM; Koczyk K; Abdulla M; Giri S; Allinson K; Matys T; Guilfoyle MR; Kirollos RW; Santarius T Acta Neurochir (Wien); 2017 Nov; 159(11):2169-2177. PubMed ID: 28791500 [TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging predicts postoperative persistence in meningioma patients with peritumoural abnormalities on magnetic resonance imaging. Nakamizo A; Inamura T; Yamaguchi S; Inoha S; Amano T; Ikezaki K; Nishio S; Nakamura Y; Fukui M J Clin Neurosci; 2003 Sep; 10(5):589-93. PubMed ID: 12948465 [TBL] [Abstract][Full Text] [Related]
10. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas. Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591 [TBL] [Abstract][Full Text] [Related]
11. Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report. Raheja A; Colman H; Palmer CA; Couldwell WT J Neurosurg; 2017 Nov; 127(5):965-970. PubMed ID: 27935362 [TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET. Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336 [TBL] [Abstract][Full Text] [Related]
13. [Clinicoradiological studies and frequency of incidental meningiomas on brain check-up]. Ikeda K; Kashihara H; Hosozawa K; Kozo A; Tamura M; Iwamoto K; Ito H; Kawase Y; Iwasaki Y Brain Nerve; 2008 Mar; 60(3):273-8. PubMed ID: 18402075 [TBL] [Abstract][Full Text] [Related]
14. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Nassehi D Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727 [TBL] [Abstract][Full Text] [Related]
15. Hormones, radiosurgery and virtual reality: new aspects of meningioma management. Black PM Can J Neurol Sci; 1997 Nov; 24(4):302-6. PubMed ID: 9398976 [TBL] [Abstract][Full Text] [Related]
17. 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? Sommerauer M; Burkhardt JK; Frontzek K; Rushing E; Buck A; Krayenbuehl N; Weller M; Schaefer N; Kuhn FP Neuro Oncol; 2016 Jul; 18(7):1021-7. PubMed ID: 26865086 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma. van de Nes JA; Griewank KG; Schmid KW; Grabellus F Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354 [TBL] [Abstract][Full Text] [Related]
19. Extracranially extended meningothelial meningiomas with a high MIB-1 index: a report of two cases. Yamada SM; Yamada S; Takahashi H; Teramoto A; Matsumoto K Neuropathology; 2004 Mar; 24(1):66-71. PubMed ID: 15068175 [TBL] [Abstract][Full Text] [Related]
20. Treatment decision making based on the published natural history and growth rate of small meningiomas. Sughrue ME; Rutkowski MJ; Aranda D; Barani IJ; McDermott MW; Parsa AT J Neurosurg; 2010 Nov; 113(5):1036-42. PubMed ID: 20433281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]